Treace Medical Concepts, Inc. (TMCI) Reports In-Line Q1 EPS

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q1 EPS of ($0.23), in-line with the analyst estimate of ($0.23). Revenue for the quarter came in at $42.2 million versus the consensus estimate of $39.25 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• Conagra Brands falls on weak fiscal 2027 earnings outlook
• Progressive Corp. (PGR) Reports Q2 EPS of $5.67
• Eos Energy reports record Q2 revenue of up to $69M, wider losses